| Prestation | Nom de la Société | Ville | Date |
|---|---|---|---|
| Principe actif (API) | Tianjin Tianyao Pharmaceuticals Co. Ltd. | Tianjin |
2025-08-12 |
| Principe actif (API) | Wuhan Biocause Pharmaceutical Development Co. Ltd. | Wuhan |
2025-08-12 |
| Principe actif (API) | Shandong Anxin Pharmaceutical Co. Ltd. | Jinan |
2025-08-14 |
| Article de conditionnement primaire (AC I) | Sanner Gmbh | Bensheim |
26/08/2025 |
| Principe actif (API) | Tonghua Dongbao Pharmaceutical Co. Ltd. | Tonghua |
2025-08-26 |
| Autres | Faiveley | Stabio |
28/08/2025 |
| Principe actif (API) | Hainan Poly Pharm Co. Ltd. | Haikou |
2025-08-28 |
| Principe actif (API) | Yichang Humanwell Pharmaceutical Co. Ltd. | Yichang |
2025-08-28 |
| Principe actif (API) | Zhejiang Jiangbei Pharmaceutical Co. Ltd. | Taizhou |
2025-09-09 |
| Principe actif (API) | Zhejiang Jiangbei Nanhai Pharmaceutical Co. Ltd. | Linhai |
2025-09-10 |
| Principe actif (API) | Zhejiang Huahai Pharmaceutical Co. Ltd. | Linhai |
2025-09-10 |
| Article de conditionnement secondaire (AC II) | SAICA Pack | Exideuil |
11/09/2025 |
| Pharmacovigilance | EGIS Pharma | Budapest |
15/09/2025 |
| Autres | Harway Pharma Co. Ltd. | Dongying |
2025-09-16 |
| Principe actif (API) | Shandong Xinhua Pharmaceutical Co. Ltd. | Zibo |
2025-09-17 |
| Analyses | Labexia | Quimper |
18/09/2025 |
| Autres | Jean Eydoux | Orange |
25/09/2025 |
| Autres | Kunming Baker Norton Pharmaceutical Co. Ltd. | Kunming |
2025-09-26 |
| Principe actif (API) | Shandong Lukang Shelile Pharmaceutical Co. Ltd. | Zoucheng |
2025-09-28 |
| Distribution | Macure | Copenhagen |
30/09/2025 |
| Pharmacovigilance | Senevet | Dakar |
30/09/2025 |
| Distribution | Kuehne Nagel | Möhlin |
01/10/2025 |
| Analyses | ACM Pharma | Bellegarde |
07/10/2025 |
| DM | Laboratoires Shadeline | Mouans-Sartoux |
08/10/2025 |
| Article de conditionnement secondaire (AC II) | LGR Girard | Le Teil |
08/10/2025 |
